Troriluzole for spinocerebellar ataxia [ID6456]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Onasemnogene abeparvovec for treating spinal muscular atrophy in people 2 years and over [TSID12168]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Filgotinib for Axial spondyloarthritis [ID6594]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC